Optimization of an Ultra-High-Throughput Screening Assay for Protein Engineering of D-Allulose 3-Epimerase

The yield problem starts with the enzyme

D-allulose tastes like sugar, but it doesn’t behave like it. It is the C-3 epimer of D-fructose, and its sweetness profile comes close to sucrose. That makes it attractive for formulators who need bulk and taste without the calorie load. But production depends on one fragile step: the enzyme that converts D-fructose into D-allulose. If the enzyme loses activity under process heat, yields drop. If it can’t be improved quickly, scale-up stalls.

This paper from Biomolecules (DOI: 10.3390/biom12111547) offers a way out. It optimizes a PsiR-based ultra-high-throughput screening assay for directed evolution of D-allulose 3-epimerase, or DAEase. The goal was not just a better enzyme. It was a faster way to find better enzymes in the first place.

What the study did

The team started with a PsiR-based screening system that can sort large libraries of enzyme variants. But high-throughput screening only works if the readout matches the property you care about. Here, the properties were specific activity and thermostability.

They used the optimized assay to evolve DAEase. One mutant, I228V, improved both activity and stability. Then they stacked additional mutations on top. The final variant carried three changes: I228V, D281G, and C289R.

That triple mutant is the headline result.

Key findings

The triple mutant outperformed the wild-type enzyme in every test that matters for manufacturing.

Metric	Wild-type DAEase	Triple mutant I228V/D281G/C289R
Relative specific activity	1.0x	1.42x
Half-life at 60°C	baseline	62.97x longer
D-fructose conversion at 70°C	21.64%	28.11%

Specific activity rose to 1.42 times the wild-type level. That means more D-allulose produced per unit of enzyme. At 60°C, the mutant’s half-life extended by 62.97 times. That is not a small gain. It transforms what a reactor can tolerate. In a biotransformation test at 70°C, the mutant converted 28.11% of D-fructose, versus 21.64% for wild-type. Higher temperature, better conversion.

The important part is the combination. A high-activity enzyme that falls apart quickly still fails in production. A stable enzyme with low activity also fails. This variant addresses both.

What it means for manufacturers

For ingredient buyers and formulation teams, the practical message is this: D-allulose cost structure can improve without new raw materials.

You still feed D-fructose to an enzyme. The enzyme still converts it to D-allulose. But a more active and more thermostable enzyme changes the economics. Higher specific activity means lower enzyme loading. Longer half-life means less enzyme replacement and more productive running time. Higher conversion at 70°C means fewer downstream separation issues or higher final yields, depending on the process design.

The screening method also matters. Directed evolution only works if you can test enough variants. The optimized PsiR-based assay accelerates that discovery loop. Future improvements may arrive faster than the previous generation of screening allowed.

If you source D-allulose or enzyme systems, ask about thermostability data. A 62-fold improvement in half-life is not a marginal tweak. It changes the design of a production line. If a supplier can’t tell you the half-life of their enzyme at process temperature, their process may still be running on older generation catalysts.

FAQ

Why does D-allulose 3-epimerase matter?
DAEase is the enzyme that converts D-fructose into D-allulose. Its activity and stability directly control production yield and cost.

What was improved in the triple mutant?
Compared to wild-type, the triple mutant had 1.42 times the specific activity, a half-life at 60°C that was 62.97 times longer, and a higher conversion rate at 70°C.

What is the advantage of the PsiR-based screening assay?
It allows high-throughput sorting of enzyme variants, so researchers can identify beneficial mutations faster than with conventional screening.

A practical angle for sourcing

None of this means every supplier uses this mutant. It means the direction is clear. The enzyme behind D-allulose is no longer a static catalyst. It can be engineered, screened, and improved in measurable steps. For formulators, that should translate into more stable supply, lower enzyme costs, and better price benchmarks. The science is moving. Ask your supplier if they are moving with it.